Eli Lilly and CompanyStock Price and Value Analysis

Should you buy Eli Lilly and Company stock? (NYSE:LLY). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantages
  • This company has an average dividend yield.
  • This company has fluctuating growth.
  • This company is very stable.
  • This company is not making money.
  • This stock looks overpriced.

LLY Free Cash Flow Trend

Hmm, we can't give any reliable projection for Eli Lilly and Company's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

Free Cash Flow trendline for LLY
Free Cash Flow trendline for Eli Lilly and Company

Inside the LLY Numbers

LLY Price
(Eli Lilly and Company stock price per share)
$86.45
[?] PE Ratio versus Sector 103% higher than other Healthcare stocks
[?] PE Ratio versus Industry 139% higher than other Drug Manufacturers - Major stocks
[?] Cash Yield 3.46%
[?] Free Cash Flow Jitter 25%
[?] Dividend Yield 2%

Is Eli Lilly and Company Stock on Sale?

Based on our analysis, we believe that you should not buy Eli Lilly and Company right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy LLY Stock?

Does Eli Lilly and Company have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.